We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Interestingly, the latest advances in AMD research also highlight common moleculardisease pathways with other neurodegenerative disorders.
2
Thus, there is a high clinical need for moleculardisease biomarkers to aid in differentiating these distinct phenotypes.
3
These cells remain after IM therapy, even when apparently complete responses are achieved, and they probably explain moleculardisease persistence.
4
These patients are typically younger and suffer from conditions caused by a known moleculardisease mechanism and a peculiar sarcopenic phenotype.
5
Fluorogenic probes that signal the presence of specific DNA or RNA sequences are key enabling tools for moleculardisease diagnosis and imaging studies.
6
Here, we performed whole exome sequencing in 79 consanguineous or familial cases of suspected nephronophthisis in order to determine the underlying moleculardisease cause.
7
Moleculardisease mechanisms downstream of functional SMN loss are still largely unknown.